New Frontiers in Biosafety and Biosecurity

Overview

Journal Front Bioeng Biotechnol

Date 2021 Aug 9

PMID 34368110

Citations 4

Authors

Alan Raybould

Affiliations

Soon will be listed here.

Citing Articles

A sustainable balance between innovation and risk: How the "right to science" affects China's medical biotechnology regulatory policy.

Han Y, Fan L, Xue Y Comput Struct Biotechnol J. 2024; 24:306-313.

PMID: 38681134 PMC: 11052690. DOI: 10.1016/j.csbj.2024.04.027.

Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.

Dama E, Orelle A, Nikiema A, Mandingar P, Naby A, Bationo G Health Secur. 2022; 20(6):479-487.

PMID: 36399610 PMC: 9805872. DOI: 10.1089/hs.2019.0069.

Regulatory frameworks can facilitate or hinder the potential for genome editing to contribute to sustainable agricultural development.

Mbaya H, Lillico S, Kemp S, Simm G, Raybould A Front Bioeng Biotechnol. 2022; 10:959236.

PMID: 36246373 PMC: 9562833. DOI: 10.3389/fbioe.2022.959236.

Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.

Xue Y, Shang L Front Bioeng Biotechnol. 2022; 10:939295.

PMID: 35860327 PMC: 9289183. DOI: 10.3389/fbioe.2022.939295.

References

Tait J, Brown A, Lalinde I, Barlow D, Chiles M, Mason P . Responsible innovation: Its role in an era of technological and regulatory transformation. Eng Biol. 2023; 5(1):2-9. PMC: 9996694. DOI: 10.1049/enb2.12005. View

Kwon C, Heo J, Lemmon Z, Capua Y, Hutton S, Van Eck J . Rapid customization of Solanaceae fruit crops for urban agriculture. Nat Biotechnol. 2019; 38(2):182-188. DOI: 10.1038/s41587-019-0361-2. View

Ricroch A . Global developments of genome editing in agriculture. Transgenic Res. 2019; 28(Suppl 2):45-52. DOI: 10.1007/s11248-019-00133-6. View

Eastman R, Roth J, Brimacombe K, Simeonov A, Shen M, Patnaik S . Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. ACS Cent Sci. 2020; 6(5):672-683. PMC: 7202249. DOI: 10.1021/acscentsci.0c00489. View

Raybould A, Poppy G . Commercializing genetically modified crops under EU regulations: objectives and barriers. GM Crops Food. 2012; 3(1):9-20. DOI: 10.4161/gmcr.18961. View

Duprex W, Fouchier R, Imperiale M, Lipsitch M, Relman D . Gain-of-function experiments: time for a real debate. Nat Rev Microbiol. 2014; 13(1):58-64. PMC: 7097416. DOI: 10.1038/nrmicro3405. View

Whelan A, Gutti P, Lema M . Gene Editing Regulation and Innovation Economics. Front Bioeng Biotechnol. 2020; 8:303. PMC: 7181966. DOI: 10.3389/fbioe.2020.00303. View

Knowlton N . Doom and gloom won't save the world. Nature. 2017; 544(7650):271. DOI: 10.1038/544271a. View

Beigel J, Tomashek K, Dodd L, Mehta A, Zingman B, Kalil A . Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020; 383(19):1813-1826. PMC: 7262788. DOI: 10.1056/NEJMoa2007764. View

10.

Clarke L, Kitney R . Developing synthetic biology for industrial biotechnology applications. Biochem Soc Trans. 2020; 48(1):113-122. PMC: 7054743. DOI: 10.1042/BST20190349. View

11.

Barrangou R, Doudna J . Applications of CRISPR technologies in research and beyond. Nat Biotechnol. 2016; 34(9):933-941. DOI: 10.1038/nbt.3659. View

12.

Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View

13.

de Campos-Rudinsky T, Undurraga E . Public health decisions in the COVID-19 pandemic require more than 'follow the science'. J Med Ethics. 2021; . DOI: 10.1136/medethics-2020-107134. View

14.

Raybould A, Macdonald P . Policy-Led Comparative Environmental Risk Assessment of Genetically Modified Crops: Testing for Increased Risk Rather Than Profiling Phenotypes Leads to Predictable and Transparent Decision-Making. Front Bioeng Biotechnol. 2018; 6:43. PMC: 5932390. DOI: 10.3389/fbioe.2018.00043. View

15.

Eichler H, Baird L, Barker R, Bloechl-Daum B, Borlum-Kristensen F, Brown J . From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. Clin Pharmacol Ther. 2015; 97(3):234-46. PMC: 6706805. DOI: 10.1002/cpt.59. View

16.

Vasiliou S, Diamandis E, Church G, Greely H, Baylis F, Thompson C . CRISPR-Cas9 System: Opportunities and Concerns. Clin Chem. 2016; 62(10):1304-11. DOI: 10.1373/clinchem.2016.263186. View

17.

Baek Y, Um J, Antigua K, Park J, Kim Y, Oh S . Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2. Emerg Microbes Infect. 2020; 9(1):998-1007. PMC: 7301696. DOI: 10.1080/22221751.2020.1756698. View

18.

Nagai S . Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan. Int J Mol Sci. 2019; 20(15). PMC: 6696404. DOI: 10.3390/ijms20153801. View

19.

Stevens A . Governments cannot just 'follow the science' on COVID-19. Nat Hum Behav. 2020; 4(6):560. DOI: 10.1038/s41562-020-0894-x. View

20.

Bogner A, Torgersen H . Precaution, Responsible Innovation and Beyond - In Search of a Sustainable Agricultural Biotechnology Policy. Front Plant Sci. 2019; 9:1884. PMC: 6305544. DOI: 10.3389/fpls.2018.01884. View